ADC Therapeutics's total assets for Q1 2025 were $272.54M, a decrease of -15.36% from the previous quarter. ADCT total liabilities were $510.76M for the fiscal quarter, a -2.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.